Bruce W Fenske

Title: Bruce W. Fenske: Innovator in Cyclosporine Analogue Molecules

Introduction

Bruce W. Fenske is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclosporine analogue molecules. With a total of 2 patents, his work has implications for immunosuppressive therapies.

Latest Patents

Fenske's latest patents focus on cyclosporine analogue molecules modified at amino acids 1 and 3. These analogs of cyclosporin-A include modifications of the substituents at these positions, which are designed to have an affinity for cyclophilin, including cyclophilin-A. Notably, these compounds exhibit reduced immunosuppressivity compared to cyclosporin-A and its analogs modified solely at position 1.

Career Highlights

Throughout his career, Bruce W. Fenske has worked with various companies, including Ciclofilin Pharmaceuticals Corp. and Contravir Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to innovative solutions in pharmaceutical development.

Collaborations

Fenske has collaborated with notable professionals in the industry, including Alexander Hegmans and Dan J. Trepanier. These collaborations have further enhanced his research and development efforts.

Conclusion

Bruce W. Fenske's contributions to the field of cyclosporine analogues highlight his innovative spirit and dedication to improving immunosuppressive therapies. His work continues to influence the pharmaceutical landscape.